Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
Breast cancer
H19
Long non-coding RNA
lncRNA
Journal
Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761
Informations de publication
Date de publication:
15 Jun 2019
15 Jun 2019
Historique:
received:
18
02
2019
revised:
08
03
2019
accepted:
19
03
2019
pubmed:
27
3
2019
medline:
1
5
2019
entrez:
27
3
2019
Statut:
ppublish
Résumé
The long non-coding RNA (lncRNA) H19 is an imprinted lncRNA with acknowledged roles in carcinogenesis. In the current study, we genotyped two single nucleotide polymorphisms (SNPs) within H19 in 111 breast cancer patients and 130 age-matched healthy subjects using tetra primer-ARMS-PCR technique. The T allele of rs2839698 conferred breast cancer risk in the assessed population (OR (95% CI) = 2.52 (1.75-3.64), adjusted P value = 1.3E-6), while and the T allele of rs217727 had a protective effect (OR (95% CI) = 0.42 (0.27-0.66), adjusted P value = 2.8E-4). Both SNPs were associated with breast cancer risk in recessive, dominant and co-dominant models. The T C haplotype (rs2839698 and rs217727) significantly increased risk of breast cancer (OR (95% CI) = 2.4 (1.65-3.45), adjusted P value = 1.2E-5), while the C T haplotype had a protective role (OR (95% CI) = 0.31 (0.18-0.52), adjusted P value = 2.03E-5). The present study highlights the role of H19 SNPs in conferring risk of breast cancer in Iranian population. Future studies with larger sample sizes are required to verify these data.
Identifiants
pubmed: 30910558
pii: S0378-1119(19)30293-8
doi: 10.1016/j.gene.2019.03.036
pii:
doi:
Substances chimiques
H19 long non-coding RNA
0
RNA, Long Noncoding
0
RNA, Neoplasm
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121-124Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.